Cadherin 5 Antikörper (AA 59-382)
Kurzübersicht für Cadherin 5 Antikörper (AA 59-382) (ABIN7427498)
Target
Alle Cadherin 5 (CDH5) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 59-382
-
Verwendungszweck
- Monoclonal Antibody to Cadherin 5 (CDH5)
-
Spezifität
- The antibody is a mouse monoclonal antibody raised against CDH5. It has been selected for its ability to recognize CDH5 in immunohistochemical staining and western blotting.
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Protein A + Protein G affinity chromatography
-
Immunogen
- Recombinant Cadherin 5 (CDH5) corresdonding to Gly59~Gly382 (Accession # NP_001100877.1)
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
- Western blotting: 0.01-2 μg/mL,Immunohistochemistry: 5-20 μg/mL,Immunocytochemistry: 5-20 μg/mL,Optimal working dilutions must be determined by end user.
-
Kommentare
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 24 months
-
-
- Cadherin 5 (CDH5)
-
Andere Bezeichnung
- CDH5
-
Hintergrund
- CD144, 7B4, Cadherin 5 Type 2, VE-Cadherin, Cadherin,Vascular Endothelial
-
UniProt
- F1M7E5
-
Pathways
- Cell-Cell Junction Organization, Signaling Events mediated by VEGFR1 and VEGFR2
Target
-